Coughlin Rainboth Murphy and Lown. New Hampshire Medical Mal-Practice Lawyers

J&J phased out hip implant after FDA request.

The New York Times (3/23, B1, Meier, Subscription Publication) reports, “Johnson & Johnson executives decided in 2009 to phase out a hip implant and sell off its inventories for use in patients just weeks after the Food and Drug Administration asked the company in a letter for added safety data about the implant, administration documents and corporate records show.” The Times adds that DePuy’s Orthopaedics unit “executives have insisted that they acted appropriately in recalling the implant model when they did.” The company “also repeatedly said that their decision to phase out the model was based on slowing product sales, rather than any factors related to the device’s safety or the Food and Drug Administration’s decision not to approve the device.”